ETANERCEPT DOSE REDUCTION IN PATIENTS WITH RHEUMATOID ARTHRITIS - A PILOT STUDY IN SOUTH WALES

被引:0
|
作者
Duffill, S. [1 ]
Kia, S. [2 ]
Amos, N. [1 ]
Thomas, E. [1 ]
机构
[1] ABMU, Rheumatol, Bridgend, Wales
[2] ABMU, Rheumatol, Swansea, W Glam, Wales
关键词
D O I
10.1136/annrheumdis-2016-eular.4552
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
FRI0193
引用
收藏
页码:500 / 500
页数:1
相关论文
共 50 条
  • [21] Etanercept treatment in patients with rheumatoid arthritis on dialysis
    Nakamura, Tadashi
    Higashi, Syu-ichi
    Tomoda, Kunihiko
    Tsukano, Michishi
    Arizono, Kenzi
    Nakamura, Takamichi
    RHEUMATOLOGY INTERNATIONAL, 2010, 30 (11) : 1527 - 1528
  • [22] EFFICACY OF ETANERCEPT IN ELDERLY PATIENTS WITH RHEUMATOID ARTHRITIS
    Edwards, C. J.
    Roshak, K.
    Bukowski, J.
    Pedersen, R.
    Thakur, M.
    Marshall, L.
    Jones, H.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 : S86 - S86
  • [23] Etanercept: therapeutic use in patients with rheumatoid arthritis
    Garrison, L
    McDonnell, ND
    ANNALS OF THE RHEUMATIC DISEASES, 1999, 58 : 65 - 69
  • [24] OPTIMIZING TREATMENT WITH ETANERCEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Rubio, E.
    Lisbona, M.
    Aguilera, C.
    Munoz, A.
    Martinez, R.
    Garrido, N.
    Alba, M. Fernandez
    Leon, P.
    Cruz, B. Hernandez
    Povedano, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 704 - 704
  • [25] Efficacy of Etanercept in Elderly Patients with Rheumatoid Arthritis
    Edwards, Christopher J.
    Roshak, Katherine
    Bukowski, Jack F.
    Pedersen, Ronald
    Thakur, Mazhar
    Marshall, Lisa
    Jones, Heather
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [26] Etanercept treatment in patients with rheumatoid arthritis on dialysis
    Tadashi Nakamura
    Syu-ichi Higashi
    Kunihiko Tomoda
    Michishi Tsukano
    Kenzi Arizono
    Takamichi Nakamura
    Rheumatology International, 2010, 30 : 1527 - 1528
  • [27] Correction to: The effective threshold dose of etanercept in patients with methotrexate-resistant rheumatoid arthritis
    Fangfang Chen
    Yitian Lang
    Shikai Geng
    Xiaodong Wang
    Liangjing Lu
    Shuang Ye
    Le Zhang
    Ting Li
    Clinical Rheumatology, 2023, 42 : 2923 - 2923
  • [28] Patients' and rheumatologists' perceptions on dose reduction of rituximab in rheumatoid arthritis
    Bertrand, Delphine
    Deprez, Anke
    Doumen, Michael
    De Cock, Diederik
    Pazmino, Sofia
    Marchal, Anja
    Thelissen, Marc
    Joly, Johan
    De Meyst, Elias
    Neerinckx, Barbara
    Westhovens, Rene
    Verschueren, Patrick
    MUSCULOSKELETAL CARE, 2024, 22 (02)
  • [29] SARILUMAB DOSE REDUCTION IN AN OPEN-LABEL EXTENSION STUDY IN RHEUMATOID ARTHRITIS PATIENTS
    Genovese, Mark C.
    Fay, Jon
    Parrino, Janie
    Beyer, Doris
    Iglesias-Rodriguez, Melitza
    Graham, Neil
    Boddy, Alex
    Martincova, Renata
    Burmester, Gerd R.
    RHEUMATOLOGY, 2017, 56 : 139 - 139
  • [30] Adalimumab and etanercept serum (anti)drug levels are not predictive for successful dose reduction or discontinuation in rheumatoid arthritis
    van Herwaarden, Noortje
    Bouman, Chantal A. M.
    van der Maas, Aatke
    van Vollenhoven, Ronald F.
    Bijlsma, Johannes W.
    van den Hoogen, Frank H. J.
    den Broeder, Alfons A.
    van den Bemt, Bart J. F.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (12) : 2260 - +